Harnessing AI and data science to discover life-changing medicines at AstraZeneca

Antibodies’ complexities require thinking around biological processes at the molecular level, Weatherall explains: “In the past, that has been a laborious process, but now we have the ability to screen up to hundreds of millions of antibody sequences per experiment. This unlocks our ability to train Machine Learning models, meaning in the future we can use AI to design antibodies to target a particular disease at speed. .”

And wherever greater volumes of data are being generated, AI is…